Year |
Citation |
Score |
2024 |
Casselini CM, Parson HK, Frizzi KE, Marquez A, Smith DR, Guernsey L, Nemmani R, Tayarani A, Jolivalt CG, Weaver J, Fernyhough P, Vinik AI, Calcutt NA. A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin. Acta Neuropathologica. 147: 60. PMID 38526612 DOI: 10.1007/s00401-024-02710-4 |
0.524 |
|
2023 |
Chen J, Frizzi K, Zardouz S, Province-Azalde R, Furnish T, Wallace M, Castellanos J, Tayerani A, Halter K, Lam K, Banducci S, Chieu A, Calcutt N. High-frequency spinal cord stimulation (10 kHz) alters sensory function and nerve fiber density in painful diabetic neuropathy: a pilot prospective open-label study. Pain Medicine (Malden, Mass.). 24: S33-S40. PMID 37833050 DOI: 10.1093/pm/pnad096 |
0.415 |
|
2023 |
Marshall A, Kalteniece A, Ferdousi M, Azmi S, Jude EB, Adamson C, D'Onofrio L, Dhage S, Soran H, Campbell J, Lee-Kubli CA, Hamdy S, Malik RA, Calcutt NA, Marshall AG. Spinal disinhibition: evidence for a hyperpathia phenotype in painful diabetic neuropathy. Brain Communications. 5: fcad051. PMID 36938521 DOI: 10.1093/braincomms/fcad051 |
0.361 |
|
2023 |
Handzlik MK, Gengatharan JM, Frizzi KE, McGregor GH, Martino C, Rahman G, Gonzalez A, Moreno AM, Green CR, Guernsey LS, Lin T, Tseng P, Ideguchi Y, Fallon RJ, Chaix A, ... ... Calcutt NA, et al. Insulin-regulated serine and lipid metabolism drive peripheral neuropathy. Nature. 614: 118-124. PMID 36697822 DOI: 10.1038/s41586-022-05637-6 |
0.397 |
|
2022 |
Jolivalt CG, Han MM, Nguyen A, Desmond F, Alves Jesus CH, Vasconselos DC, Pedneault A, Sandlin N, Dunne-Cerami S, Frizzi KE, Calcutt NA. Using Corneal Confocal Microscopy to Identify Therapeutic Agents for Diabetic Neuropathy. Journal of Clinical Medicine. 11. PMID 35566433 DOI: 10.3390/jcm11092307 |
0.412 |
|
2022 |
Aghanoori MR, Agarwal P, Gauvin E, Nagalingam RS, Bonomo R, Yathindranath V, Smith DR, Hai Y, Lee S, Jolivalt CG, Calcutt NA, Jones MJ, Czubryt MP, Miller DW, Dolinsky VW, et al. CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth. Cellular and Molecular Life Sciences : Cmls. 79: 193. PMID 35298717 DOI: 10.1007/s00018-022-04201-9 |
0.443 |
|
2022 |
Zhou X, Zhu Y, Wang Z, Lin Z, Zhu D, Xie C, Calcutt NA, Guan Y. Rate-dependent Depression: A Predictor of the Therapeutic Efficacy in Treating Painful Diabetic Peripheral Neuropathy. Diabetes. PMID 35234842 DOI: 10.2337/db21-0960 |
0.393 |
|
2021 |
Worthington A, Kalteniece A, Ferdousi M, D'Onofrio L, Dhage S, Azmi S, Adamson C, Hamdy S, Malik RA, Calcutt NA, Marshall AG. Spinal Inhibitory Dysfunction in Patients With Painful or Painless Diabetic Neuropathy. Diabetes Care. 44: 1835-1841. PMID 34385346 DOI: 10.2337/dc20-2797 |
0.427 |
|
2021 |
Worthington A, Kalteniece A, Ferdousi M, D'Onofrio L, Dhage S, Azmi S, Adamson C, Hamdy S, Malik RA, Calcutt NA, Marshall AG. Optimal Utility of H-Reflex RDD as a Biomarker of Spinal Disinhibition in Painful and Painless Diabetic Neuropathy. Diagnostics (Basel, Switzerland). 11. PMID 34359330 DOI: 10.3390/diagnostics11071247 |
0.406 |
|
2021 |
Jin HY, Moon SS, Calcutt NA. Lost in Translation? Measuring Diabetic Neuropathy in Humans and Animals (Diabetes Metab J 2021;45:27-42). Diabetes & Metabolism Journal. 45: 457-458. PMID 34044488 DOI: 10.4093/dmj.2021.0034 |
0.463 |
|
2021 |
Marshall A, Alam U, Themistocleous A, Calcutt N, Marshall A. Novel and Emerging Electrophysiological Biomarkers of Diabetic Neuropathy and Painful Diabetic Neuropathy. Clinical Therapeutics. PMID 33906790 DOI: 10.1016/j.clinthera.2021.03.020 |
0.453 |
|
2021 |
Lee-Kubli CA, Zhou X, Jolivalt CG, Calcutt NA. Pharmacological Modulation of Rate-Dependent Depression of the Spinal H-Reflex Predicts Therapeutic Efficacy against Painful Diabetic Neuropathy. Diagnostics (Basel, Switzerland). 11. PMID 33670344 DOI: 10.3390/diagnostics11020283 |
0.414 |
|
2020 |
Jin HY, Moon SS, Calcutt NA. Lost in Translation? Measuring Diabetic Neuropathy in Humans and Animals. Diabetes & Metabolism Journal. PMID 33307618 DOI: 10.4093/dmj.2020.0216 |
0.452 |
|
2020 |
Calcutt NA. Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms? Pain. 161: S65-S86. PMID 32999525 DOI: 10.1097/J.Pain.0000000000001922 |
0.562 |
|
2020 |
Yang W, Sung K, Xu W, Rodriguez MJ, Wu AC, Santos SA, Fang S, Uber RK, Dong SX, Guillory BC, Orain X, Raus J, Jolivalt C, Calcutt N, Rissman RA, et al. A Missense Point Mutation in Nerve Growth Factor (NGF) Results in Selective Peripheral Sensory Neuropathy. Progress in Neurobiology. 101886. PMID 32693191 DOI: 10.1016/J.Pneurobio.2020.101886 |
0.375 |
|
2020 |
Malik RA, Calcutt NA. Translating Diabetic Peripheral Neuropathy. Journal of the Peripheral Nervous System : Jpns. PMID 32394617 DOI: 10.1111/Jns.12384 |
0.597 |
|
2020 |
Jolivalt CG, Frizzi KE, Han MM, Mota AJ, Guernsey LS, Kotra LP, Fernyhough P, Calcutt NA. Topical delivery of muscarinic receptor antagonists prevents and reverses peripheral neuropathy in female diabetic mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 32327528 DOI: 10.1124/Jpet.120.265447 |
0.561 |
|
2020 |
Saleh A, Sabbir MG, Aghanoori MR, Smith DR, Roy Chowdhury SK, Tessler L, Brown J, Gedarevich E, Kassahun MZ, Frizzi K, Calcutt NA, Fernyhough P. Muscarinic Toxin 7 Signals Via Ca/Calmodulin-Dependent Protein Kinase Kinase β to Augment Mitochondrial Function and Prevent Neurodegeneration. Molecular Neurobiology. PMID 32198698 DOI: 10.1007/S12035-020-01900-X |
0.451 |
|
2019 |
Jolivalt CG, Marquez A, Quach D, Navarro Diaz MC, Anaya C, Kifle B, Muttalib N, Sanchez G, Guernsey L, Hefferan M, Smith DR, Fernyhough P, Johe K, Calcutt NA. Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189. Diabetes. PMID 31492662 DOI: 10.2337/Db19-0271 |
0.511 |
|
2019 |
Stacpoole PW, Martyniuk CJ, James MO, Calcutt NA. Dichloroacetate-induced peripheral neuropathy. International Review of Neurobiology. 145: 211-238. PMID 31208525 DOI: 10.1016/Bs.Irn.2019.05.003 |
0.319 |
|
2018 |
Yorek M, Malik RA, Calcutt NA, Vinik A, Yagihashi S. Diabetic Neuropathy: New Insights to Early Diagnosis and Treatments. Journal of Diabetes Research. 2018: 5378439. PMID 30648115 DOI: 10.1155/2018/5378439 |
0.5 |
|
2018 |
Aghanoori MR, Smith DR, Shariati-Ievari S, Ajisebutu A, Nguyen A, Desmond F, Jesus CHA, Zhou X, Calcutt NA, Aliani M, Fernyhough P. Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes. Molecular Metabolism. PMID 30545741 DOI: 10.1016/J.Molmet.2018.11.008 |
0.497 |
|
2018 |
Villalón E, Barry DM, Byers N, Frizzi K, Jones MR, Landayan DS, Dale JM, Downer NL, Calcutt NA, Garcia ML. Internode length is reduced during myelination and remyelination by neurofilament medium phosphorylation in motor axons. Experimental Neurology. PMID 29772247 DOI: 10.1016/J.Expneurol.2018.05.009 |
0.307 |
|
2018 |
Lee-Kubli C, Marshall AG, Malik RA, Calcutt NA. The H-Reflex as a Biomarker for Spinal Disinhibition in Painful Diabetic Neuropathy. Current Diabetes Reports. 18: 1. PMID 29362940 DOI: 10.1007/S11892-018-0969-5 |
0.433 |
|
2018 |
VINIK AI, CALCUTT NA, EDWARDS JF, WEAVER JR, BAILEY MD, FERNYHOUGH P, CUNDRA LB, FRIZZI KE, PARSON H, CASELLINI CM. Muscarinic Receptor Antagonist Improves Nerve Fiber Function in Subjects with Type 2 Diabetes and Peripheral Neuropathy Diabetes. 67: 58-OR. DOI: 10.2337/Db18-58-Or |
0.45 |
|
2017 |
Daugherty DJ, Marquez A, Calcutt NA, Schubert D. A novel curcumin derivative for the treatment of diabetic neuropathy. Neuropharmacology. PMID 29122628 DOI: 10.1016/J.Neuropharm.2017.11.007 |
0.607 |
|
2017 |
Aghanoori MR, Smith DR, Chowdhury SR, Sabbir MG, Calcutt NA, Fernyhough P. Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats. Experimental Neurology. PMID 28803751 DOI: 10.1016/J.Expneurol.2017.08.005 |
0.529 |
|
2017 |
Marshall AG, Lee-Kubli C, Azmi S, Zhang M, Ferdousi M, Mixcoatl-Zecuatl T, Petropoulos IN, Ponirakis G, Fineman MS, Fadavi H, Frizzi K, Tavakoli M, Jeziorska M, Jolivalt CG, Boulton AJ, ... ... Calcutt NA, et al. Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy. Diabetes. PMID 28202580 DOI: 10.2337/Db16-1181 |
0.594 |
|
2017 |
Gonçalves NP, Vægter CB, Andersen H, Østergaard L, Calcutt NA, Jensen TS. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nature Reviews. Neurology. PMID 28134254 DOI: 10.1038/Nrneurol.2016.201 |
0.583 |
|
2017 |
Calcutt NA, Smith DR, Frizzi K, Sabbir MG, Chowdhury SK, Mixcoatl-Zecuatl T, Saleh A, Muttalib N, Van der Ploeg R, Ochoa J, Gopaul A, Tessler L, Wess J, Jolivalt CG, Fernyhough P. Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy. The Journal of Clinical Investigation. PMID 28094765 DOI: 10.1172/Jci88321 |
0.506 |
|
2016 |
Jolivalt CG, Frizzi KE, Guernsey L, Marquez A, Ochoa J, Rodriguez M, Calcutt NA. Peripheral Neuropathy in Mouse Models of Diabetes. Current Protocols in Mouse Biology. 6: 223-55. PMID 27584552 DOI: 10.1002/Cpmo.11 |
0.595 |
|
2016 |
Fernyhough P, Calcutt NA. New Directions in Diabetic Neuropathy: Evolution or Extinction? International Review of Neurobiology. 127: 229-34. PMID 27133152 DOI: 10.1016/bs.irn.2016.03.009 |
0.457 |
|
2016 |
Fernyhough P, Calcutt NA. An Introduction to the History and Controversies of the Pathogenesis of Diabetic Neuropathy. International Review of Neurobiology. 127: 115-20. PMID 27133147 DOI: 10.1016/Bs.Irn.2016.03.012 |
0.575 |
|
2016 |
Calcutt NA, Fernyhough P. An Introduction to the History and Controversies of Animal Models of Diabetic Neuropathy. International Review of Neurobiology. 127: 45-52. PMID 27133144 DOI: 10.1016/Bs.Irn.2016.03.011 |
0.547 |
|
2016 |
Calcutt NA, Fernyhough P. A Brief Introduction to the History and Controversies of Clinical Trials in Diabetic Neuropathy. International Review of Neurobiology. 127: 3-8. PMID 27133141 DOI: 10.1016/Bs.Irn.2016.03.014 |
0.478 |
|
2016 |
Bravo-Hernández M, Corleto JA, Barragán-Iglesias P, González-Ramírez R, Pineda-Farias JB, Felix R, Calcutt NA, Delgado-Lezama R, Marsala M, Granados-Soto V. The α5 subunit containing GABAA receptors contribute to chronic pain. Pain. 157: 613-26. PMID 26545088 DOI: 10.1097/J.Pain.0000000000000410 |
0.325 |
|
2015 |
Jolivalt CG, Rodriguez M, Wahren J, Calcutt NA. Efficacy of a long-acting C-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice. Diabetes, Obesity & Metabolism. 17: 781-8. PMID 25904006 DOI: 10.1111/Dom.12477 |
0.394 |
|
2015 |
Hollis ER, Ishiko N, Tolentino K, Doherty E, Rodriguez MJ, Calcutt NA, Zou Y. A novel and robust conditioning lesion induced by ethidium bromide. Experimental Neurology. 265: 30-9. PMID 25541322 DOI: 10.1016/J.Expneurol.2014.12.004 |
0.415 |
|
2014 |
Lee-Kubli CA, Calcutt NA. Painful neuropathy: Mechanisms. Handbook of Clinical Neurology. 126: 533-57. PMID 25410243 DOI: 10.1016/B978-0-444-53480-4.00034-5 |
0.457 |
|
2014 |
Biessels GJ, Bril V, Calcutt NA, Cameron NE, Cotter MA, Dobrowsky R, Feldman EL, Fernyhough P, Jakobsen J, Malik RA, Mizisin AP, Oates PJ, Obrosova IG, Pop-Busui R, Russell JW, et al. Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). Journal of the Peripheral Nervous System : Jpns. 19: 77-87. PMID 24934510 DOI: 10.1111/Jns5.12072 |
0.582 |
|
2014 |
Chowdhury SR, Saleh A, Akude E, Smith DR, Morrow D, Tessler L, Calcutt NA, Fernyhough P. Ciliary neurotrophic factor reverses aberrant mitochondrial bioenergetics through the JAK/STAT pathway in cultured sensory neurons derived from streptozotocin-induced diabetic rodents. Cellular and Molecular Neurobiology. 34: 643-9. PMID 24682898 DOI: 10.1007/S10571-014-0054-9 |
0.521 |
|
2014 |
Lee-Kubli CA, Mixcoatl-Zecuatl T, Jolivalt CG, Calcutt NA. Animal models of diabetes-induced neuropathic pain. Current Topics in Behavioral Neurosciences. 20: 147-70. PMID 24510303 DOI: 10.1007/7854_2014_280 |
0.552 |
|
2014 |
Hedstrom KL, Murtie JC, Albers K, Calcutt NA, Corfas G. Treating small fiber neuropathy by topical application of a small molecule modulator of ligand-induced GFRα/RET receptor signaling. Proceedings of the National Academy of Sciences of the United States of America. 111: 2325-30. PMID 24449858 DOI: 10.1073/Pnas.1308889111 |
0.38 |
|
2014 |
Lee-Kubli CA, Calcutt NA. Altered rate-dependent depression of the spinal H-reflex as an indicator of spinal disinhibition in models of neuropathic pain. Pain. 155: 250-60. PMID 24103402 DOI: 10.1016/J.Pain.2013.10.001 |
0.464 |
|
2014 |
Chowdhury SR, Smith D, Calcutt N, Fernyhough P. Muscarinic Toxin 7, a Specific Acetylcholine Muscarinic Type 1 Receptor Antagonist, Corrects Deficits in Mitochondrial Bioenergetics in Cultured Sensory Neurons Derived from Diabetic Rodents Canadian Journal of Diabetes. 38: S62. DOI: 10.1016/J.Jcjd.2014.07.174 |
0.422 |
|
2014 |
Smith D, Frizzi K, Cundiff M, Calcutt N, Fernyhough P. Oxybutynin, a Muscarinic Receptor Antagonist Reverses Sensory Neuropathy and Corrects Deficits in Intraepidermal Nerve Fibre Density and Corneal Nerve Fibre Density of Diabetic Mice Canadian Journal of Diabetes. 38: S60-S61. DOI: 10.1016/J.Jcjd.2014.07.168 |
0.495 |
|
2014 |
Saleh A, Tessler L, Czubryt M, Calcutt N, Fernyhough P. Acetylcholine Muscarinic Type 1 Receptor (M1R) Antagonists Modulate Nerve Growth Through a Ca2+/Calmodulin-Dependent Kinase Kinase 2 (CaMKK2) Pathway in Adult Sensory Neurons Canadian Journal of Diabetes. 38: S14. DOI: 10.1016/J.Jcjd.2014.07.034 |
0.305 |
|
2013 |
Calcutt NA. Location, location, location?: is the pain of diabetic neuropathy generated by hyperactive sensory neurons? Diabetes. 62: 3658-60. PMID 24158992 DOI: 10.2337/Db13-1158 |
0.408 |
|
2013 |
Chen DK, Frizzi KE, Guernsey LS, Ladt K, Mizisin AP, Calcutt NA. Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin. Journal of the Peripheral Nervous System : Jpns. 18: 306-15. PMID 24147903 DOI: 10.1111/Jns5.12044 |
0.627 |
|
2013 |
Hadimani MB, Purohit MK, Vanampally C, Van der Ploeg R, Arballo V, Morrow D, Frizzi KE, Calcutt NA, Fernyhough P, Kotra LP. Guaifenesin derivatives promote neurite outgrowth and protect diabetic mice from neuropathy. Journal of Medicinal Chemistry. 56: 5071-8. PMID 23758573 DOI: 10.1021/Jm400401Y |
0.442 |
|
2013 |
Saleh A, Roy Chowdhury SK, Smith DR, Balakrishnan S, Tessler L, Martens C, Morrow D, Schartner E, Frizzi KE, Calcutt NA, Fernyhough P. Ciliary neurotrophic factor activates NF-κB to enhance mitochondrial bioenergetics and prevent neuropathy in sensory neurons of streptozotocin-induced diabetic rodents. Neuropharmacology. 65: 65-73. PMID 23022047 DOI: 10.1016/J.Neuropharm.2012.09.015 |
0.541 |
|
2012 |
Gregory JA, Jolivalt CG, Goor J, Mizisin AP, Calcutt NA. Hypertension-induced peripheral neuropathy and the combined effects of hypertension and diabetes on nerve structure and function in rats. Acta Neuropathologica. 124: 561-73. PMID 22791295 DOI: 10.1007/S00401-012-1012-6 |
0.834 |
|
2012 |
Roy Chowdhury SK, Smith DR, Saleh A, Schapansky J, Marquez A, Gomes S, Akude E, Morrow D, Calcutt NA, Fernyhough P. Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes. Brain : a Journal of Neurology. 135: 1751-66. PMID 22561641 DOI: 10.1093/Brain/Aws097 |
0.513 |
|
2012 |
Jolivalt CG, Calcutt NA, Masliah E. Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease. Neuroscience. 202: 405-12. PMID 22178988 DOI: 10.1016/J.Neuroscience.2011.11.032 |
0.491 |
|
2011 |
Jolivalt CG, Fineman M, Deacon CF, Carr RD, Calcutt NA. GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice. Diabetes, Obesity & Metabolism. 13: 990-1000. PMID 21635674 DOI: 10.1111/J.1463-1326.2011.01431.X |
0.519 |
|
2010 |
Calcutt NA. Tolerating diabetes: an alternative therapeutic approach for diabetic neuropathy. Asn Neuro. 2: e00042. PMID 20842208 DOI: 10.1042/An20100026 |
0.544 |
|
2010 |
Chowdhury SK, Zherebitskaya E, Smith DR, Akude E, Chattopadhyay S, Jolivalt CG, Calcutt NA, Fernyhough P. Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment. Diabetes. 59: 1082-91. PMID 20103706 DOI: 10.2337/Db09-1299 |
0.429 |
|
2010 |
Fernyhough P, Calcutt NA. Abnormal calcium homeostasis in peripheral neuropathies. Cell Calcium. 47: 130-9. PMID 20034667 DOI: 10.1016/J.Ceca.2009.11.008 |
0.368 |
|
2010 |
Ehren J, Calcutt N, Maher P. Fisetin: Flavonoid and Fighter of Diabetic Complications Free Radical Biology and Medicine. 49: S181. DOI: 10.1016/J.Freeradbiomed.2010.10.515 |
0.547 |
|
2009 |
Davidson E, Coppey L, Lu B, Arballo V, Calcutt NA, Gerard C, Yorek M. The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy. Experimental Diabetes Research. 2009: 431980. PMID 20148083 DOI: 10.1155/2009/431980 |
0.525 |
|
2009 |
Calcutt NA, Lopez VL, Bautista AD, Mizisin LM, Torres BR, Shroads AL, Mizisin AP, Stacpoole PW. Peripheral neuropathy in rats exposed to dichloroacetate. Journal of Neuropathology and Experimental Neurology. 68: 985-93. PMID 19680144 DOI: 10.1097/Nen.0B013E3181B40217 |
0.485 |
|
2009 |
Malisza KL, Jones C, Gruwel ML, Foreman D, Fernyhough P, Calcutt NA. Functional magnetic resonance imaging of the spinal cord during sensory stimulation in diabetic rats. Journal of Magnetic Resonance Imaging : Jmri. 30: 271-6. PMID 19629995 DOI: 10.1002/Jmri.21856 |
0.544 |
|
2009 |
Calcutt NA, Cooper ME, Kern TS, Schmidt AM. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nature Reviews. Drug Discovery. 8: 417-29. PMID 19404313 DOI: 10.1038/Nrd2476 |
0.523 |
|
2009 |
Jolivalt CG, Mizisin LM, Nelson A, Cunha JM, Ramos KM, Bonke D, Calcutt NA. B vitamins alleviate indices of neuropathic pain in diabetic rats. European Journal of Pharmacology. 612: 41-7. PMID 19393643 DOI: 10.1016/J.Ejphar.2009.04.028 |
0.798 |
|
2009 |
Burdo JR, Chen Q, Calcutt NA, Schubert D. The pathological interaction between diabetes and presymptomatic Alzheimer's disease. Neurobiology of Aging. 30: 1910-7. PMID 18372080 DOI: 10.1016/J.Neurobiolaging.2008.02.010 |
0.392 |
|
2008 |
Jolivalt CG, Lee CA, Ramos KM, Calcutt NA. Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters. Pain. 140: 48-57. PMID 18755547 DOI: 10.1016/J.Pain.2008.07.005 |
0.798 |
|
2008 |
Beiswenger KK, Calcutt NA, Mizisin AP. Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice. Neuroscience Letters. 442: 267-72. PMID 18619518 DOI: 10.1016/J.Neulet.2008.06.079 |
0.822 |
|
2008 |
Jolivalt CG, Vu Y, Mizisin LM, Mizisin AP, Calcutt NA. Impaired prosaposin secretion during nerve regeneration in diabetic rats and protection of nerve regeneration by a prosaposin-derived peptide. Journal of Neuropathology and Experimental Neurology. 67: 702-10. PMID 18596543 DOI: 10.1097/Nen.0B013E31817E23F4 |
0.61 |
|
2008 |
Cunha JM, Jolivalt CG, Ramos KM, Gregory JA, Calcutt NA, Mizisin AP. Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors. Metabolism: Clinical and Experimental. 57: 873-81. PMID 18555826 DOI: 10.1016/J.Metabol.2008.01.021 |
0.822 |
|
2008 |
Beiswenger KK, Calcutt NA, Mizisin AP. Epidermal nerve fiber quantification in the assessment of diabetic neuropathy. Acta Histochemica. 110: 351-62. PMID 18384843 DOI: 10.1016/J.Acthis.2007.12.004 |
0.829 |
|
2008 |
Calcutt NA, Jolivalt CG, Fernyhough P. Growth factors as therapeutics for diabetic neuropathy. Current Drug Targets. 9: 47-59. PMID 18220712 DOI: 10.2174/138945008783431727 |
0.513 |
|
2008 |
Jolivalt CG, Dacunha JM, Esch FS, Calcutt NA. Central action of prosaptide TX14(A) against gp120-induced allodynia in rats. European Journal of Pain (London, England). 12: 76-81. PMID 17466547 DOI: 10.1016/J.Ejpain.2007.03.008 |
0.393 |
|
2007 |
Calcutt NA, Backonja MM. Pathogenesis of pain in peripheral diabetic neuropathy. Current Diabetes Reports. 7: 429-34. PMID 18255005 DOI: 10.1007/S11892-007-0072-9 |
0.445 |
|
2007 |
Landgraf RR, Garrett TJ, Calcutt NA, Stacpoole PW, Yost RA. MALDI-linear ion trap microprobe MS/MS studies of the effects of dichloroacetate on lipid content of nerve tissue. Analytical Chemistry. 79: 8170-5. PMID 17894472 DOI: 10.1021/Ac0713555 |
0.323 |
|
2007 |
Ramos KM, Jiang Y, Svensson CI, Calcutt NA. Pathogenesis of spinally mediated hyperalgesia in diabetes. Diabetes. 56: 1569-76. PMID 17287466 DOI: 10.2337/Db06-1269 |
0.815 |
|
2007 |
Gregory JA, Mizisin AP, Halilovic A, Printz MP, Calcutt NA. The effects of concurrent hypertension on the development of peripheral neuropathy in STZ-diabetic rats: 558.13 Journal of Neuropathology and Experimental Neurology. 66: 452. DOI: 10.1097/01.Jnen.0000268948.23568.40 |
0.822 |
|
2007 |
Gregory JA, Mizisin AP, Halilovic A, Printz MP, Calcutt NA. The effects of concurrent hypertension on the development of peripheral neuropathy in STZ-diabetic rats Journal of Neuropathology and Experimental Neurology. 66: 452. DOI: 10.1096/Fasebj.21.5.A401-A |
0.822 |
|
2006 |
Jiang Y, Calcutt NA, Ramos KM, Rames KM, Mizisin AP. Novel sites of aldose reductase immunolocalization in normal and streptozotocin-diabetic rats. Journal of the Peripheral Nervous System : Jpns. 11: 274-85. PMID 17117935 DOI: 10.1111/J.1529-8027.2006.00099.X |
0.814 |
|
2006 |
Jolivalt CG, Jiang Y, Freshwater JD, Bartoszyk GD, Calcutt NA. Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats. Diabetologia. 49: 2775-85. PMID 16924480 DOI: 10.1007/S00125-006-0397-Y |
0.824 |
|
2006 |
Malmberg AB, O'Connor WT, Glennon JC, Ceseña R, Calcutt NA. Impaired formalin-evoked changes of spinal amino acid levels in diabetic rats. Brain Research. 1115: 48-53. PMID 16920081 DOI: 10.1016/J.Brainres.2006.07.077 |
0.565 |
|
2006 |
Calcutt NA, Freshwater JD, Hauptmann N, Taylor EM, Mizisin AP. Protection of sensory function in diabetic rats by Neotrofin. European Journal of Pharmacology. 534: 187-93. PMID 16507305 DOI: 10.1016/J.Ejphar.2006.01.047 |
0.85 |
|
2006 |
Jolivalt CG, Ramos KM, Herbetsson K, Esch FS, Calcutt NA. Therapeutic efficacy of prosaposin-derived peptide on different models of allodynia. Pain. 121: 14-21. PMID 16480831 DOI: 10.1016/J.Pain.2005.11.013 |
0.791 |
|
2006 |
Stacpoole P, Shroads A, Felitsyn N, Notterpek L, Calcutt N. Mechanism and age dependence of dichloroacetate-induced peripheral neuropathy Mitochondrion. 6: 17-18. DOI: 10.1016/J.Mito.2006.08.042 |
0.312 |
|
2005 |
Freshwater JD, Calcutt NA. Low Doses of Formalin Reveal Allodynia in Diabetic Rats Journal of Neuropathic Pain & Symptom Palliation. 1: 39-46. DOI: 10.3109/J426v01n01_08 |
0.831 |
|
2004 |
Malmberg AB, Mizisin AP, Calcutt NA, von Stein T, Robbins WR, Bley KR. Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain. 111: 360-7. PMID 15363880 DOI: 10.1016/J.Pain.2004.07.017 |
0.336 |
|
2004 |
Calcutt NA, Freshwater JD, Mizisin AP. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia. 47: 718-24. PMID 15298349 DOI: 10.1007/S00125-004-1354-2 |
0.84 |
|
2004 |
Mizisin AP, Vu Y, Shuff M, Calcutt NA. Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats. Diabetes. 53: 1807-12. PMID 15220205 DOI: 10.2337/Diabetes.53.7.1807 |
0.625 |
|
2004 |
Calcutt NA. Experimental models of painful diabetic neuropathy. Journal of the Neurological Sciences. 220: 137-9. PMID 15140623 DOI: 10.1016/J.Jns.2004.03.015 |
0.492 |
|
2004 |
Calcutt NA. Modeling diabetic sensory neuropathy in rats. Methods in Molecular Medicine. 99: 55-65. PMID 15131329 DOI: 10.1385/1-59259-770-X:055 |
0.51 |
|
2004 |
Calcutt NA. Textbook of Diabetic Neuropathy Journal of the Peripheral Nervous System. 9: 58-58. DOI: 10.1111/J.1085-9489.2004.09202.X |
0.585 |
|
2003 |
Svensson CI, Marsala M, Westerlund A, Calcutt NA, Campana WM, Freshwater JD, Catalano R, Feng Y, Protter AA, Scott B, Yaksh TL. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. Journal of Neurochemistry. 86: 1534-44. PMID 12950462 DOI: 10.1046/J.1471-4159.2003.01969.X |
0.761 |
|
2003 |
Sayers NM, Beswick LJ, Middlemas A, Calcutt NA, Mizisin AP, Tomlinson DR, Fernyhough P. Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats. Diabetes. 52: 2372-80. PMID 12941778 DOI: 10.2337/Diabetes.52.9.2372 |
0.547 |
|
2003 |
Huang TJ, Price SA, Chilton L, Calcutt NA, Tomlinson DR, Verkhratsky A, Fernyhough P. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes. 52: 2129-36. PMID 12882932 DOI: 10.2337/Diabetes.52.8.2129 |
0.526 |
|
2003 |
Calcutt NA, Allendoerfer KL, Mizisin AP, Middlemas A, Freshwater JD, Burgers M, Ranciato R, Delcroix JD, Taylor FR, Shapiro R, Strauch K, Dudek H, Engber TM, Galdes A, Rubin LL, et al. Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy. The Journal of Clinical Investigation. 111: 507-14. PMID 12588889 DOI: 10.1172/jci15792 |
0.854 |
|
2002 |
Calcutt NA. Future treatments for diabetic neuropathy: clues from experimental neuropathy. Current Diabetes Reports. 2: 482-8. PMID 12643154 DOI: 10.1007/S11892-002-0117-Z |
0.586 |
|
2002 |
Luo ZD, Calcutt NA, Higuera ES, Valder CR, Song YH, Svensson CI, Myers RR. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. The Journal of Pharmacology and Experimental Therapeutics. 303: 1199-205. PMID 12438544 DOI: 10.1124/Jpet.102.041574 |
0.438 |
|
2002 |
Calcutt NA. Potential mechanisms of neuropathic pain in diabetes. International Review of Neurobiology. 50: 205-28. PMID 12198811 DOI: 10.1016/S0074-7742(02)50078-7 |
0.561 |
|
2002 |
Freshwater JD, Svensson CI, Malmberg AB, Calcutt NA. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes. 51: 2249-55. PMID 12086957 DOI: 10.2337/Diabetes.51.7.2249 |
0.83 |
|
2001 |
Mizisin AP, Steinhardt RC, O'Brien JS, Calcutt NA. TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed rats. Journal of Neuropathology and Experimental Neurology. 60: 953-60. PMID 11589426 DOI: 10.1093/Jnen/60.10.953 |
0.613 |
|
2001 |
Rende M, Brizi E, Donato R, Provenzano C, Bruno R, Mizisin AP, Garrett RS, Calcutt NA, Campana WM, O'Brien JS. Prosaposin is immunolocalized to muscle and prosaptides promote myoblast fusion and attenuate loss of muscle mass after nerve injury Muscle and Nerve. 24: 799-808. PMID 11360264 DOI: 10.1002/Mus.1072 |
0.302 |
|
2000 |
Campana WM, Mohiuddin L, Misasi R, O'Brien JS, Calcutt NA. Prosaposin-derived peptides enhanced sprouting of sensory neurons in vitro and induced sprouting at motor endplates in vivo. Journal of the Peripheral Nervous System : Jpns. 5: 126-30. PMID 11442168 DOI: 10.1046/J.1529-8027.2000.00019.X |
0.309 |
|
2000 |
Calcutt NA, Freshwater JD, O'Brien JS. Protection of sensory function and antihyperalgesic properties of a prosaposin-derived peptide in diabetic rats. Anesthesiology. 93: 1271-8. PMID 11046216 DOI: 10.1097/00000542-200011000-00021 |
0.845 |
|
2000 |
Calcutt NA, Stiller C, Gustafsson H, Malmberg AB. Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats. Brain Research. 856: 20-7. PMID 10677607 DOI: 10.1016/S0006-8993(99)02345-8 |
0.492 |
|
1999 |
Mizisin AP, Calcutt NA, Tomlinson DR, Gallagher A, Fernyhough P. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats. Journal of the Peripheral Nervous System : Jpns. 4: 211-21. PMID 10642089 |
0.498 |
|
1999 |
Luo ZD, Chaplan SR, Scott BP, Cizkova D, Calcutt NA, Yaksh TL. Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: lack of a role in allodynia development. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 9201-8. PMID 10531423 DOI: 10.1523/Jneurosci.19-21-09201.1999 |
0.505 |
|
1999 |
Calcutt NA, Campana WM, Eskeland NL, Mohiuddin L, Dines KC, Mizisin AP, O'Brien JS. Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats. Journal of Neuropathology and Experimental Neurology. 58: 628-36. PMID 10374753 DOI: 10.1097/00005072-199906000-00007 |
0.532 |
|
1999 |
Dines KC, Calcutt NA, Nunag KD, Mizisin AP, Kalichman MW. Effects of hindlimb temperature on sciatic nerve laser Doppler vascular conductance in control and streptozotocin-diabetic rats. Journal of the Neurological Sciences. 163: 17-24. PMID 10223405 DOI: 10.1016/S0022-510X(99)00013-1 |
0.583 |
|
1999 |
Ceseña RM, Calcutt NA. Gabapentin prevents hyperalgesia during the formalin test in diabetic rats. Neuroscience Letters. 262: 101-4. PMID 10203241 DOI: 10.1016/S0304-3940(99)00057-9 |
0.592 |
|
1998 |
Calcutt NA, Chen P, Hua XY. Effects of diabetes on tissue content and evoked release of calcitonin gene-related peptide-like immunoreactivity from rat sensory nerves. Neuroscience Letters. 254: 129-32. PMID 10214974 DOI: 10.1016/S0304-3940(98)00692-2 |
0.56 |
|
1998 |
Calcutt NA, Dines KC, Ceseña RM. Effects of the peptide HP228 on nerve disorders in diabetic rats. Metabolism: Clinical and Experimental. 47: 650-6. PMID 9627361 DOI: 10.1016/S0026-0495(98)90025-7 |
0.642 |
|
1998 |
Ng DTF, Lee FK, Song ZT, Calcutt NA, Lee LW, Chung SSM, Chung SK. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice Diabetes. 47: 961-966. PMID 9604875 DOI: 10.2337/Diabetes.47.6.961 |
0.521 |
|
1997 |
Okuse K, Chaplan SR, McMahon SB, Luo ZD, Calcutt NA, Scott BP, Akopian AN, Wood JN. Regulation of expression of the sensory neuron-specific sodium channel SNS in inflammatory and neuropathic pain. Molecular and Cellular Neurosciences. 10: 196-207. PMID 9532581 DOI: 10.1006/Mcne.1997.0657 |
0.411 |
|
1997 |
Calcutt NA, Chaplan SR. Spinal pharmacology of tactile allodynia in diabetic rats. British Journal of Pharmacology. 122: 1478-82. PMID 9421298 DOI: 10.1038/Sj.Bjp.0701538 |
0.52 |
|
1997 |
Mizisin AP, Bache M, DiStefano PS, Acheson A, Lindsay RM, Calcutt NA. BDNF attenuates functional and structural disorders in nerves of galactose-fed rats. Journal of Neuropathology and Experimental Neurology. 56: 1290-301. PMID 9413278 DOI: 10.1097/00005072-199712000-00004 |
0.43 |
|
1997 |
Hua XY, Calcutt NA, Malmberg AB. Neonatal capsaicin treatment abolishes formalin-induced spinal PGE2 release. Neuroreport. 8: 2325-9. PMID 9243634 DOI: 10.1097/00001756-199707070-00045 |
0.362 |
|
1997 |
Mizisin AP, Calcutt NA, DiStefano PS, Acheson A, Longo FM. Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats. Diabetes. 46: 647-52. PMID 9075806 DOI: 10.2337/Diab.46.4.647 |
0.419 |
|
1996 |
Calcutt NA, Jorge MC, Yaksh TL, Chaplan SR. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain. 68: 293-9. PMID 9121817 DOI: 10.1016/S0304-3959(96)03201-0 |
0.647 |
|
1996 |
Brett FM, Kalichman MW, Calcutt NA, Mizisin AP. Effects of seven days of galactose feeding and aldose reductase inhibition on mast cells and vessel morphometry in rat sciatic nerve. Journal of the Neurological Sciences. 141: 6-12. PMID 8880685 DOI: 10.1016/0022-510X(96)00136-0 |
0.369 |
|
1996 |
Mizisin AP, Li L, Perello M, Freshwater JD, Kalichman MW, Roux L, Calcutt NA. Polyol pathway and osmoregulation in JS1 Schwann cells grown in hyperglycemic and hyperosmotic conditions. The American Journal of Physiology. 270: F90-7. PMID 8769826 DOI: 10.1152/Ajprenal.1996.270.1.F90 |
0.74 |
|
1996 |
Belai A, Calcutt NA, Carrington AL, Diemel LT, Tomlinson DR, Burnstock G. Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition. Journal of the Autonomic Nervous System. 58: 163-9. PMID 8738309 DOI: 10.1016/0165-1838(95)00129-8 |
0.577 |
|
1995 |
Calcutt NA, Li L, Yaksh TL, Malmberg AB. Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. European Journal of Pharmacology. 285: 189-97. PMID 8566138 DOI: 10.1016/0014-2999(95)00402-7 |
0.56 |
|
1995 |
Kalichman MW, Powell HC, Calcutt NA, Mizisin AP. Mast cell degranulation and blood-nerve barrier permeability in rat sciatic nerve after 7 days of hyperglycemia. The American Journal of Physiology. 268: H740-8. PMID 7864200 DOI: 10.1152/Ajpheart.1995.268.2.H740 |
0.488 |
|
1994 |
Calcutt NA, Mizisin AP, Kalichman MW. Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve. European Journal of Pharmacology. 251: 27-33. PMID 8137868 DOI: 10.1016/0014-2999(94)90439-1 |
0.552 |
|
1994 |
Calcutt NA, McMurray HF, Moorhouse DF, Bache M, Parthasarathy S, Powell HC, Mizisin AP. Inhibition of macrophage chemotaxis and peripheral nerve regeneration in normal and hyperglycemic rats by the aldose reductase inhibitor Tolrestat. Experimental Neurology. 128: 226-32. PMID 8076666 DOI: 10.1006/Exnr.1994.1131 |
0.495 |
|
1994 |
Calcutt NA, Malmberg AB, Yamamoto T, Yaksh TL. Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats. Pain. 58: 413-20. PMID 7838591 DOI: 10.1016/0304-3959(94)90136-8 |
0.561 |
|
1993 |
Mizisin AP, Kalichman MW, Calcutt NA, Myers RR, Powell HC. Decreased endoneurial fluid electrolytes in normal rat sciatic nerve after aldose reductase inhibition. Journal of the Neurological Sciences. 116: 67-72. PMID 8389817 DOI: 10.1016/0022-510X(93)90091-C |
0.483 |
|
1993 |
Carrington AL, Calcutt NA, Ettlinger CB, Gustafsson T, Tomlinson DR. Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes. European Journal of Pharmacology. 237: 257-63. PMID 8365454 DOI: 10.1016/0014-2999(93)90277-O |
0.523 |
|
1993 |
Calcutt NA, Mizisin AP, Yaksh TL. Impaired induction of vasoactive intestinal polypeptide after sciatic nerve injury in the streptozotocin-diabetic rat. Journal of the Neurological Sciences. 119: 154-61. PMID 8277329 DOI: 10.1016/0022-510X(93)90128-L |
0.568 |
|
1993 |
Malmberg AB, Yaksh TL, Calcutt NA. Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats. Neuroscience Letters. 161: 45-8. PMID 8255545 DOI: 10.1016/0304-3940(93)90136-9 |
0.586 |
|
1993 |
Moorhouse DF, Calcutt NA, Bache M, Mizisin AP, Powell HC. EFFECTS OF HYPERGLYCEMIA AND THE ALDOSE REDUCTASE INHIBITOR TOLRESTAT ON PERIPHERAL NERVE REGENERATION IN RATS Journal of Neuropathology and Experimental Neurology. 52: 276. DOI: 10.1097/00005072-199305000-00064 |
0.468 |
|
1992 |
Calcutt NA, Muir D, Powell HC, Mizisin AP. Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed rats. Brain Research. 575: 320-4. PMID 1571789 DOI: 10.1016/0006-8993(92)90097-S |
0.604 |
|
1992 |
Kalichman MW, Calcutt NA. Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats. Anesthesiology. 77: 941-7. PMID 1443749 DOI: 10.1097/00000542-199211000-00017 |
0.587 |
|
1992 |
Calcutt NA, Carrington AL, Ettlinger CB, Tomlinson DR. The effect of mixed bovine brain gangliosides on hypoxic conduction block in control and streptozotocin-diabetic rats. Journal of the Neurological Sciences. 109: 96-101. PMID 1387680 DOI: 10.1016/0022-510X(92)90100-Y |
0.578 |
|
1991 |
Calcutt NA, Ettlinger CB, Carrington AL, Diemel L, Tomlinson DR. Resistance to hypoxic conduction block in sciatic nerves of rats with streptozotocin-induced diabetes mellitus. Journal of the Neurological Sciences. 103: 116-23. PMID 1865225 DOI: 10.1016/0022-510X(91)90294-H |
0.596 |
|
1991 |
Willars GB, Calcutt NA, Tomlinson DR. Nerve conduction velocity and axonal transport of 6-phosphofructokinase activity in galactose-fed rats. Journal of the Neurological Sciences. 104: 46-51. PMID 1717661 DOI: 10.1016/0022-510X(91)90214-R |
0.529 |
|
1991 |
Mizisin AP, Calcutt NA. Dose-dependent alterations in nerve polyols and (Na+,K+)-ATPase activity in galactose intoxication. Metabolism: Clinical and Experimental. 40: 1207-12. PMID 1658547 DOI: 10.1016/0026-0495(91)90217-K |
0.397 |
|
1991 |
Carrington AL, Ettlinger CB, Calcutt NA, Tomlinson DR. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats. Diabetologia. 34: 397-401. PMID 1653157 DOI: 10.1007/Bf00403177 |
0.563 |
|
1990 |
Calcutt NA, Tomlinson DR, Biswas S. Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy. Diabetes. 39: 663-6. PMID 2161366 DOI: 10.2337/Diab.39.6.663 |
0.366 |
|
1990 |
Calcutt NA, Tomlinson DR, Willars GB, Keen P. Axonal transport of substance P-like immunoreactivity in ganglioside-treated diabetic rats. Journal of the Neurological Sciences. 96: 283-91. PMID 1695917 DOI: 10.1016/0022-510X(90)90139-E |
0.637 |
|
1989 |
Willars GB, Calcutt NA, Compton AM, Tomlinson DR, Keen P. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition. Journal of the Neurological Sciences. 91: 153-64. PMID 2473171 DOI: 10.1016/0022-510X(89)90084-1 |
0.64 |
|
1989 |
Tomlinson DR, Willars GB, Calcutt NA, Compton AM, Macdonald IA, Clarke HE, Keen P. Effects of sorbinil treatment in rats with chronic streptozotocin-diabetes; changes in lens and in substance P and catecholamines in the iris. Current Eye Research. 8: 357-63. PMID 2470551 DOI: 10.3109/02713688908996383 |
0.566 |
|
1988 |
Calcutt NA, Willars GB, Tomlinson DR. Statil-sensitive polyol formation in nerve of galactose-fed mice. Metabolism: Clinical and Experimental. 37: 450-3. PMID 3130544 DOI: 10.1016/0026-0495(88)90045-5 |
0.505 |
|
1988 |
Lambourne JE, Brown AM, Calcutt N, Tomlinson DR, Willars GB. Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition. Diabetologia. 31: 379-84. PMID 2970984 DOI: 10.1007/Bf02341507 |
0.562 |
|
1988 |
Calcutt NA, Tomlinson DR, Willars GB. Ganglioside treatment of diabetic rats; effects on nerve adenosine triphosphatase activity and motor nerve conduction velocity. Life Sciences. 42: 1515-20. PMID 2965293 DOI: 10.1016/0024-3205(88)90008-2 |
0.614 |
|
1988 |
Calcutt NA, Willars GB, Tomlinson DR. Axonal transport of choline acetyltransferase and 6-phosphofructokinase activities in genetically diabetic mice. Muscle & Nerve. 11: 1206-10. PMID 2467203 DOI: 10.1002/Mus.880111204 |
0.508 |
|
1988 |
Calcutt NA, Tomlinson DR, Willars GB. Ganglioside treatment of streptozotocin-diabetic rats prevents defective axonal transport of 6-phosphofructokinase activity. Journal of Neurochemistry. 50: 1478-83. PMID 2452237 DOI: 10.1111/J.1471-4159.1988.Tb03033.X |
0.601 |
|
1987 |
Willars GB, Calcutt NA, Tomlinson DR. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'. Diabetologia. 30: 239-43. PMID 2439402 DOI: 10.1007/Bf00270422 |
0.622 |
|
Show low-probability matches. |